Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol prolonged-release versus morphine prolonged-release in pediatric chronic pain
2012-004360-22Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tapentadol in chronic pain (2 arms), sponsored by Grünenthal GmbH. Started Aug 2014; status: completed.
02
Drugs
tapentadol
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2012-004360-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004360-22.